EAM Global Investors’s T2 Biosystems, Inc TTOO Stock Holding History

EAM Global Investors’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30	Closed	-$1.15M	–	197
2018 Q2	$1.15M	Buy	+30	New	+$1.14M	0.56%	106

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Global Investors's TTOO Position: Q3 2018 in Review

EAM Global Investors sold out of T2 Biosystems, Inc (TTOO) in Q3 2018, closing a stake of 30 shares — an estimated $1.15M sold.

EAM Global Investors first reported a position in TTOO in Q2 2018 and held it in 1 quarter. The position peaked at $1.15M in Q2 2018. 85 funds tracked by Wall St. Rank hold TTOO as of Q3 2018.

EAM Global Investors reported no remaining T2 Biosystems, Inc position as of Q3 2018 after selling out during the quarter.
EAM Global Investors sold 30 T2 Biosystems, Inc shares in Q3 2018, an estimated $1.15M.
EAM Global Investors first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 1 quarter.
EAM Global Investors's T2 Biosystems, Inc position peaked at $1.15M in Q2 2018.
85 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2018.

Based on EAM Global Investors's 13F filing for Q3 2018, filed 8 Nov 2018.